Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Transplant ; 11(9): 1792-802, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21812920

ABSTRACT

The first Banff proposal for the diagnosis of pancreas rejection (Am J Transplant 2008; 8: 237) dealt primarily with the diagnosis of acute T-cell-mediated rejection (ACMR), while only tentatively addressing issues pertaining to antibody-mediated rejection (AMR). This document presents comprehensive guidelines for the diagnosis of AMR, first proposed at the 10th Banff Conference on Allograft Pathology and refined by a broad-based multidisciplinary panel. Pancreatic AMR is best identified by a combination of serological and immunohistopathological findings consisting of (i) identification of circulating donor-specific antibodies, and histopathological data including (ii) morphological evidence of microvascular tissue injury and (iii) C4d staining in interacinar capillaries. Acute AMR is diagnosed conclusively if these three elements are present, whereas a diagnosis of suspicious for AMR is rendered if only two elements are identified. The identification of only one diagnostic element is not sufficient for the diagnosis of AMR but should prompt heightened clinical vigilance. AMR and ACMR may coexist, and should be recognized and graded independently. This proposal is based on our current knowledge of the pathogenesis of pancreas rejection and currently available tools for diagnosis. A systematized clinicopathological approach to AMR is essential for the development and assessment of much needed therapeutic interventions.


Subject(s)
Autoantibodies/immunology , Graft Rejection/diagnosis , Pancreas Transplantation/immunology , Practice Guidelines as Topic , Graft Rejection/immunology , Humans
2.
Am J Transplant ; 10(12): 2717-22, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21114649

ABSTRACT

Pancreas transplantation is an effective treatment option for patients with complicated diabetes mellitus. Pancreas allograft recipients are followed with laboratory markers such as serum amylase, lipase and glucose levels. Hyperglycemia may indicate severe acute rejection and has recently been associated with antibody-mediated (humoral) rejection. In this report, we describe a unique case of a pancreas-after-kidney (PAK) transplant recipient with the rare presentation of pancreatic panniculitis, biopsy-proven severe acute cellular and antibody-mediated pancreas allograft rejection and surprisingly well-preserved endocrine function despite treatment with high dose steroids. We discuss the clinicopathologic features of antibody-mediated pancreas rejection, including the importance of correlating pancreas allograft biopsy, C4d staining and donor specific antibodies, to diagnose antibody-mediated rejection and initiate the correct treatment.


Subject(s)
Diabetic Nephropathies/surgery , Kidney/physiology , Pancreas Transplantation , Pancreatic Diseases/etiology , Panniculitis/etiology , Adult , Cytomegalovirus Infections/drug therapy , Female , Ganciclovir/therapeutic use , Graft Rejection/drug therapy , Graft Rejection/immunology , Humans , Immunoglobulins, Intravenous/therapeutic use , Kidney Transplantation/immunology , Pancreas Transplantation/adverse effects , Plasmapheresis
SELECTION OF CITATIONS
SEARCH DETAIL
...